Prognostic Model of Hypertension
PHOP-HT
1 other identifier
observational
50,000
1 country
1
Brief Summary
The aim of this study was to establish a registration and monitoring system for hypertension in Xinjiang from 2020 to 2030 to obtain real information about patient basic information, patient characteristics, diagnostic test patterns, treatment options, and hospitalization outcomes (including mortality). Treatment complications, hospitalization costs, and end-of-life events (death, major adverse cardiac events, mild adverse cardiovascular events) in patients with hypertension in Xinjiang; and scientific prevention strategies aimed at effectively preventing the onset of hypertension; Guidelines in clinical practice recommend, analyze and develop effective treatment strategies to optimize management and outcomes for patients with hypertension; and create cost-effective assessment systems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
November 29, 2023
CompletedFirst Posted
Study publicly available on registry
December 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2030
March 28, 2024
March 1, 2024
10 years
November 29, 2023
March 26, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Resistant hypertension
10 years of follow-up Resistant hypertension occurred during this period
Death (all-cause mortality, mortality from hypertension complications)
10 years of follow-up deaths occurred during this period
Secondary Outcomes (1)
Major adverse cardiovascular events
10 years of follow-up deaths occurred during this period
Study Arms (1)
2
Interventions
Eligibility Criteria
A patient diagnosed with primary hypertension who was admitted to the First Affiliated Hospital of Xinjiang Medical University
You may qualify if:
- A patient diagnosed with primary hypertension who was admitted to the First Affiliated Hospital of Xinjiang Medical University
You may not qualify if:
- Patients with secondary hypertension, patients with liver and kidney dysfunction,
- patients with mental disorders, and patients who are unwilling to participate in this trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Xinjiang Medicial University
Ürümqi, Xinjiang, 830000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Xiangxie, MD,The First Affiliated Hospital Of XinJiang Medicial University
Study Record Dates
First Submitted
November 29, 2023
First Posted
December 7, 2023
Study Start
January 1, 2020
Primary Completion (Estimated)
January 1, 2030
Study Completion (Estimated)
January 1, 2030
Last Updated
March 28, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share